Intravenous (IV) Iron Drugs - 2015 Global Strategic

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Intravenous (IV) Iron Drugs - 2015 Global Strategic Business Report - Feraheme Surges Ahead; Manufacturer Eyes Expansion of Indications

Dublin, March 13, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/sm...avenous_iv ) has announced the addition of the "Intravenous (IV) Iron Drugs - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The report profiles 17 companies including many key and niche players such as:

  • Actavis, Inc. (US)
  • AMAG Pharmaceuticals, Inc. (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Galenica Ltd. (Switzerland)
  • Vifor Pharma Ltd. (Switzerland)
  • Luitpold Pharmaceuticals, Inc. (US)
  • American Regent, Inc. (US)
  • Pharmacosmos A/S (Denmark)
  • Sanofi US (US)
  • Takeda Pharmaceutical Company Limited (Japan)

Key Topics Covered:

1. OUTLOOK

  • IV Iron Drugs Market
  • A Quick Primer
  • US and Europe Dominate IV Iron Market
  • Asia-Pacific
  • The Fastest Growing Market
  • Recession Fails to Affect Market Growth
  • Positive Outlook for the Healthcare Industry Signals Prospects

2. INDUSTRY OVERVIEW & TRENDS

  • IDA and Treatment
  • An Overview
  • Dialysis Clinics
  • Major Market for IV Iron Supplements
  • IV Iron Drugs
  • An Overview
  • Select IV Iron Drugs Prescribed for Iron Deficiency
  • Galenica
  • The Global Leader in IV Iron
  • Venofer®
  • Galenica's Wonder Drug
  • Venofer Continues to Lose Ground
  • Ferinject/Injectafer
  • A Promising Revenue Spinner for Galenica
  • Feraheme Surges Ahead; Manufacturer Eyes Expansion of Indications
  • The Vulnerable Ageing Population Supports Demand
  • Changing Preferences Favor IV Iron Drugs
  • Comparison of Ferrous Salts with IV Iron Therapy
  • Chronic Kidney Disease
  • The Predominant Growth Factor
  • Other Chronic Diseases with IDA Offer Prospects for IV Iron Drugs
  • Anemia in Heart Failure
  • A Market with Huge Potential
  • Chemotherapy Induced Anemia to Promote IV Iron Supplements
  • Correction of IDA in Pregnancy Signals Opportunities
  • Women's Health
  • Key Growth Opportunity
  • Perioperative and Postoperative Anemia
  • A Niche Market Beckons
  • Adverse Reactions of IV Iron Preparations Raise Concerns
  • Peginesatide
  • A Possible Threat to IV Iron
  • Dosing Limitations Plague IV Iron Market
  • Select Therapeutic Areas and the Required Iron Doses

3. REGULATORY OVERVIEW

  • Increasing Trend towards Bundled Reimbursements
  • A Glimpse of Regulations in the US and Europe
  • Comparison of Approved Indications and Safety Warnings for Select FDA Approved IV Iron Drugs
  • Coverage of IV Iron and ESA in the Reimbursement Packages of Dialysis Services across Belgium, Germany, Netherlands, the UK, France, the US and Ontario, Canada

4. OVERVIEW OF INTRAVENOUS (IV) IRON DRUGS

  • Iron
  • A Vital Element
  • Iron-Deficiency Anemia
  • Intravenous Therapy
  • Patients of Chronic Illnesses, the Elderly and Women
  • The High Risk Population
  • Treatment for Iron Deficiency Anemia
  • Iron Requirement in Chronic Kidney Disease
  • Classification of Iron Deficiency in CKD
  • Treating Iron Deficiency in CKD Patients
  • Side Effects of Iron Supplementation in CKD
  • Methods of Restoring Iron
  • Oral Iron Therapy
  • IV Iron-Infusion Therapy
  • Intravenous (IV) Iron
  • Conditions for Receiving Iron Injections
  • Injection Procedure
  • Categories of Iron Injections
  • Suitability of IV Iron Preparation
  • Suitability of Regimen
  • Management of Iron Doses
  • Effectiveness of Iron Injection
  • Requirement of Test Dose
  • Adverse Effects of Iron Injections
  • Iron Therapy: Caution
  • Duration of Iron Infusion
  • Iron Overdose
  • Iron-Out-of-Balance Therapies
  • Blood Donation
  • Therapeutic Phlebotomy
  • Red Cell Apheresis
  • Iron Chelation Therapy
  • Iron-Chelating Drugs
  • Desferrioxamine or Desferal
  • Deferiprone or Ferriprox
  • Conditions for Undergoing Iron Chelation Therapy
  • Kinds of Chelation Therapy
  • Side Effects Caused by IV Iron Chelation

5. PRODUCT LAUNCHES/APPROVALS

  • FDA approves Injectafer® for the Treatment of IDA
  • Takeda Pharmaceutical Company Introduces Rienso® in Europe
  • Pharmacosmos Launches Monofer® Intravenous Iron Drug

6. RECENT INDUSTRY ACTIVITY

  • American Regent Steps Up Injectafer® Promotions
  • AMAG Files for Rienso Label Expansion in Europe
  • AMAG Receives FDA Complete Response Letter for Feraheme®
  • Vifor Pharma and Zeria Pharmaceutical Co., Ltd. Sign Exclusive Licensing Agreement for Ferinject® in Japan
  • Watson Pharmaceuticals Changes Name to Actavis
  • Luitpold Pharmaceuticals Obtains FDA Acceptance for Review of Injectafer® NDA
  • AMAG Pharmaceuticals Receives FDA Acceptance for Feraheme® sNDA Review
  • Takeda Issues Rienso Recall in Switzerland
  • EC Approves Takeda's Rienso® to Treat Anemia
  • BioLink Life Sciences to Commence Phase I Trial of FCP

7. FOCUS ON SELECT PLAYERS

  • Actavis, Inc. (US)
  • AMAG Pharmaceuticals, Inc. (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Galenica Ltd. (Switzerland)
  • Vifor Pharma Ltd. (Switzerland)
  • Luitpold Pharmaceuticals, Inc. (US)
  • American Regent, Inc. (US)
  • Pharmacosmos A/S (Denmark)
  • Sanofi US (US)
  • Takeda Pharmaceutical Company Limited (Japan)

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 17 (including Divisions/Subsidiaries 20)

  • The United States (6)
  • Japan (2)
  • Europe (5)
  • Germany (1)
  • Rest of Europe (4)
  • Asia-Pacific (Excluding Japan) (7)

For more information visit http://www.researchandmarkets.com/research/sm...avenous_iv


CONTACT: CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Pharmaceuticals

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 102

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 120

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 107

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Central Florida Buyers Face the Cash Reality First

Updated Category News Views 128

A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 119

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Cloud Security’s $26.8 Billion Test Is All About Execution

Updated Category News Views 65

A cloud dashboard that spits out ten thousand alerts is not protection; it is an expensive way to make a security team miserable. That frustration sits right in the middle of Frost & Sullivan’s projection that global cloud security revenue will climb from $8.4 billion in 2025 to $26.8 billion by 2031, a 21.4% compound annual growth rate. The number is hefty, no...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 82

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
Triller Lawsuit Puts Merger Disclosures Under a Harsh Light

Updated Category News Views 90

A $0.32 closing price has a way of stripping the paint off a corporate story. The proposed securities class action involving Triller Group, Inc. puts a hard spotlight on a familiar, ugly market sequence: a splashy merger, glowing talk around acquired assets, delayed financial filings, Nasdaq trouble, and then a collapse severe enough to leave shareholders wondering what...

Continue Reading

Top 5 Most Recently Viewed Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 420

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
BW LPG Limited Welcomes BW Chinook: A Significant Milestone

Updated Category News Views 180

Significant Acquisition by BW LPG Limited BW LPG Limited has recently taken a remarkable step in enhancing its fleet and operational capabilities. The company announced the acquisition of the vessel BW Chinook, marking an important milestone in its ongoing strategy to strengthen its position in the global LPG market. Details of the Vessel Delivery Following a stock...

Continue Reading
COMAC's Expansion: New Hong Kong Office and Maintenance Deal

Updated Category News Views 175

COMAC's Global Expansion Efforts Chinese planemaker COMAC has taken a significant step in its quest to enter the global passenger jet market by inaugurating its second international office in Hong Kong. This move aligns with their strategy to provide enhanced services and establish a stronger footprint outside mainland China. The opening not only symbolizes growth but...

Continue Reading
Torrid Holdings CEO Lisa Harper Makes Strategic Stock Move

Updated Category News Views 415

Lisa Harper's Recent Sale of Company Shares Lisa Harper, the CEO of Torrid Holdings Inc. (NYSE: CURV), has recently sold shares worth $283,909, according to a filing with the Securities and Exchange Commission. In this transaction, she sold 74,713 shares at a price of $3.80 each. This sale is part of her exercise of the underwriters' option to purchase additional shares...

Continue Reading
Getty Images Plans Q3 2024 Financial Results Release Date

Updated Category News Views 102

Getty Images Announces Q3 2024 Financial Results Date Getty Images Holdings, Inc. (NYSE: GETY), a leader in the global visual content industry, is gearing up to share its financial results for the third quarter of 2024. The results will be unveiled right after market closing on November 7, 2024. This announcement signals an important moment for stakeholders keeping a...

Continue Reading